Health Care & Life Sciences » Pharmaceuticals | Biofermin Pharmaceutical Co. Ltd.

Biofermin Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
10,533
10,846
9,666
10,619
10,877
11,543
Cost of Goods Sold (COGS) incl. D&A
3,682
4,076
3,869
4,068
3,810
4,594
Gross Income
6,851
6,769
5,797
6,551
7,068
6,949
SG&A Expense
4,201
3,402
3,427
3,758
3,698
3,612
EBIT
2,647
3,365
2,278
2,699
3,193
3,176
Unusual Expense
-
-
48
-
-
30
Non Operating Income/Expense
83
101
65
10
85
127
Pretax Income
3,297
3,468
2,299
2,710
3,108
3,274
Income Tax
1,135
1,193
710
810
897
968
Consolidated Net Income
2,162
2,276
1,590
1,899
2,211
2,305
Net Income
2,162
2,276
1,590
1,899
2,211
2,305
Net Income After Extraordinaries
2,162
2,276
1,590
1,899
2,211
2,305
Net Income Available to Common
2,162
2,276
1,590
1,899
2,211
2,305
EPS (Basic)
181.03
190.56
133.11
159.06
185.04
192.79
Basic Shares Outstanding
12
12
12
12
12
12
EPS (Diluted)
181.03
190.56
133.05
158.83
184.76
192.60
Diluted Shares Outstanding
12
12
12
12
12
12
EBITDA
3,810
4,883
3,530
3,793
4,120
4,117
Other Operating Expense
2
2
92
95
177
161
Non-Operating Interest Income
2
2
4
1
1
1

About Biofermin Pharmaceutical Co.

View Profile
Address
Sannomiya Central Building, 12/F
Kobe Hyogo 650
Japan
Employees -
Website http://www.biofermin.co.jp
Updated 07/08/2019
Biofermin Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products, quasi-drugs, veterinary drugs, agrichemicals, cosmetics, medical equipment, foods, beverages, food additives, feeds, feed additives and other chemicals. Its products include pharmaceutical items such as New Biofermin S, Biofermin Antidiarrheal, Biofermin, Stomachic Tablets, Biofermin VC, Biofermin Laxatives, Biofermin R, etc. It also provides various clinical test services.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.